|
Jun 27
|
NOV Announces Second Quarter 2025 Earnings Conference Call
|
|
May 2
|
NOV Inc. Just Missed EPS By 23%: Here's What Analysts Think Will Happen Next
|
|
May 1
|
NOV Inc. price target lowered to $17 from $20 at JPMorgan
|
|
Feb 26
|
What Eli Lilly's $27B investment in US manufacturing means for GLP-1s
|
|
Feb 16
|
NOV Full Year 2024 Earnings: EPS Beats Expectations
|